Dengfeng Ren
Impact in
- Oncology top 5%
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
-
- Advanced Breast Cancer Therapies
- Lung Cancer Treatments and Mutations
- Gastric Cancer Management and Outcomes
Papers in
- Oncology 19
- HER2/EGFR in Cancer Research 6
- Cancer Immunotherapy and Biomarkers 5
- Cancer Treatment and Pharmacology 4
-
- Gastric Cancer Management and Outcomes 8
- Advanced Breast Cancer Therapies 5
- Co-authors
- Jiuda Zhao (42 shared papers)Fuxing Zhao (43 shared papers)Guoshuang Shen (37 shared papers)Raees Ahmad (8 shared papers)Feng Du (7 shared papers)Fangchao Zheng (7 shared papers)Qiuxia Dong (10 shared papers)Ziyi Wang (1 shared paper)
- Journals
- Clinical and Experimental Medicine (5 papers)Critical Reviews in Oncology/Hematology (4 papers)BMC Cancer (4 papers)Journal of Environmental Pathology Toxicology and Oncology (3 papers)Frontiers in Oncology (3 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Dengfeng Ren
44 papers receiving 866 citations
Dengfeng Ren's Hit Papers
Peers
Comparison fields: 5 of 78
- Oncology 396
- Pulmonary and Respiratory Medicine 221
- Cancer Research 101
- Health Informatics 6
- Gastroenterology 14
Countries citing papers authored by Dengfeng Ren
This map shows the geographic impact of Dengfeng Ren's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dengfeng Ren with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dengfeng Ren more than expected).
Fields of papers citing papers by Dengfeng Ren
This network shows the impact of papers produced by Dengfeng Ren. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dengfeng Ren. The network helps show where Dengfeng Ren may publish in the future.
Co-authors
The 25 scholars most cited alongside Dengfeng Ren, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development Hit paper breakdown → | 2018 | 465 |
| 2 | 2020 | 56 | |
| 3 | 2021 | 30 | |
| 4 | 2023 | 27 | |
| 5 | 2021 | 26 | |
| 6 | 2019 | 21 | |
| 7 | 2023 | 17 | |
| 8 | 2021 | 16 | |
| 9 | 2020 | 15 | |
| 10 | 2021 | 14 | |
| 11 | 2023 | 13 | |
| 12 | 2023 | 11 | |
| 13 | 2021 | 11 | |
| 14 | 2022 | 10 | |
| 15 | 2023 | 9 | |
| 16 | 2024 | 9 | |
| 17 | 2022 | 9 | |
| 18 | 2023 | 9 | |
| 19 | 2021 | 8 | |
| 20 | 2022 | 8 |
About Dengfeng Ren
Dengfeng Ren is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Molecular Biology, having authored 49 papers that have together received 871 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (8 papers), Gastric Cancer Management and Outcomes (8 papers), HER2/EGFR in Cancer Research (6 papers), Advanced Breast Cancer Therapies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer Treatment and Pharmacology (4 papers), Drilling and Well Engineering (2 papers) and Cancer Genomics and Diagnostics (2 papers). The work is most often cited by research in Oncology (396 citations), Pulmonary and Respiratory Medicine (221 citations), Cancer Research (101 citations), Health Informatics (6 citations) and Gastroenterology (14 citations). Dengfeng Ren has collaborated with scholars based in China and United States. Frequent co-authors include Jiuda Zhao, Fuxing Zhao, Guoshuang Shen, Raees Ahmad, Feng Du, Fangchao Zheng, Qiuxia Dong, Ziyi Wang, Jinming Li and Yong‐Hui Zheng. Their work appears in journals such as Clinical and Experimental Medicine, Critical Reviews in Oncology/Hematology, BMC Cancer, Journal of Environmental Pathology Toxicology and Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.